Cormorant Asset Management’s Corvus Pharmaceuticals CRVS Stock Holding History

Cormorant Asset Management’s Portfolio CRVS Stock Details CRVS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell
2017 Q1	$1.68M	Sell
2016 Q4	$2.84M	Sell
2016 Q3	$3.52M	Hold
2016 Q2	$3.05M	Buy